On July 11, Argenx SE fell 3.66% in regular trading, trading at 877.51 USD/share, with Turnover of $178 million.
Within the Biotechnology sector where Argenx SE belongs, the overall sector performance was weak. Among individual stocks, AbbVie down 1.32%, Ionis Pharmaceuticals down 8.46%, Moderna down 10.42%, Gilead Sciences down 3.26%, Alnylam Pharmaceuticals down 4.37%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments